What is Amycretin?
The short answer
Amycretin is a peptide, a short chain of amino acids.
What it is
Amycretin: Unimolecular GLP-1 + amylin agonist (peptide).
One molecule hitting GLP-1 and amylin receptors.
What people look into
Weight
- 3 sources
- Status as of
- How we source
- Ellum doesn't sell peptides.
Get updates on Amycretin
What it is
- Also known as
- nnc0487-0111
- How it works
- One molecule hitting GLP-1 and amylin receptors.
Regulatory status
Investigational (phase 3) How we label status
As of October 4, 2026, Amycretin is not FDA-approved for any use and is not on FDA's 503A bulks list. It is in phase 3 trials.
- Federal (FDA)
- Investigational, phase 3 started 2026 (AMAZE), not filed
- 503A compounding
- No category; not on 216.23 as of 2026-10-07; not an approved-drug component (as of October 7, 2026)
References
Sources as of October 4, 2026